ZDA
AGN

Zweig-DiMenna Associates’s Allergan plc AGN Stock Holding History

Zweig-DiMenna Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-21,000
Closed -$4.84M – 280
2016
Q3 		$4.84M Buy
+21,000
New +$5.13M 0.39% 78

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Zweig-DiMenna Associates's AGN Position: Q2 2020 in Review

Zweig-DiMenna Associates sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 317,095 shares — an estimated $56.2M sold.

Zweig-DiMenna Associates first reported a position in AGN in Q1 2014 and held it in 18 quarters. The position peaked at $81.8M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Zweig-DiMenna Associates reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 317,095 Allergan plc shares in Q2 2020, an estimated $56.2M.
  • Zweig-DiMenna Associates first reported a position in Allergan plc in Q1 2014 and held it in 18 quarters.
  • Zweig-DiMenna Associates's Allergan plc position peaked at $81.8M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Zweig-DiMenna Associates's 13F filing for Q2 2020, filed 29 Jul 2020.